CA Stock MarketDetailed Quotes
VM Voyageur Pharmaceuticals Ltd
- 0.060
- -0.005-7.69%
15min DelayMarket Closed Nov 22 16:00 ET
8.37MMarket Cap-6000P/E (TTM)
0.065High0.060Low46.00KVolume0.065Open0.065Pre Close2.81KTurnover0.09052wk High0.04%Turnover Ratio139.47MShares0.03552wk Low-0.01EPS TTM7.51MFloat Cap0.400Historical HighLossP/E (Static)125.12MShs Float0.035Historical Low-0.01EPS LYR7.69%Amplitude--Dividend TTM8.57P/B1Lot Size--Div YieldTTM
Voyageur Pharmaceuticals Ltd Key Stats
Quarterly+Annual
YOY
| (Q3)Aug 31, 2024 | (Q2)May 31, 2024 | (Q1)Feb 29, 2024 | (FY)Nov 30, 2023 | (Q4)Nov 30, 2023 | (Q3)Aug 31, 2023 | (Q2)May 31, 2023 | (Q1)Feb 28, 2023 | (FY)Nov 30, 2022 | (Q4)Nov 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 174.80%359.13K | -9.59%561.9K | -11.97%328.95K | -23.15%1.35M | -59.98%229.24K | -69.38%130.69K | 30.42%621.49K | 51.08%373.69K | -14.46%1.75M | 11.32%572.81K |
| Selling and administrative expenses | 245.75%249.39K | -1.53%404.54K | 19.09%279.06K | -12.52%940.01K | -38.17%231.46K | -72.27%72.13K | 24.70%410.84K | 132.10%234.31K | -27.01%1.07M | 12.71%374.35K |
| -General and administrative expense | 245.75%249.39K | -1.53%404.54K | 19.09%279.06K | -12.52%940.01K | -38.17%231.46K | -72.27%72.13K | 24.70%410.84K | 132.10%234.31K | -27.01%1.07M | 12.71%374.35K |
| Research and development costs | 73.64%64.37K | -36.83%104.82K | -85.53%12.63K | -46.75%280.94K | -109.74%-9.37K | -73.75%37.07K | 19.91%165.95K | -39.88%87.29K | 6.25%527.56K | -39.00%96.15K |
| Depreciation amortization depletion | -28.02%393 | -28.02%393 | -28.02%393 | -24.86%2.19K | -24.90%546 | -24.90%546 | -24.90%546 | -24.90%546 | 29.47%2.91K | -67.63%727 |
| -Depreciation and amortization | -28.02%393 | -28.02%393 | -28.02%393 | -24.86%2.19K | -24.90%546 | -24.90%546 | -24.90%546 | -24.90%546 | 29.47%2.91K | -67.63%727 |
| Other operating expenses | 114.77%44.98K | 18.10%52.15K | -28.47%36.87K | -16.11%123.24K | -93.50%6.6K | -15.50%20.94K | 455.85%44.16K | 10,614.97%51.54K | 90.26%146.91K | 350.47%101.58K |
| Operating profit | -174.80%-359.13K | 9.59%-561.9K | 11.97%-328.95K | 23.15%-1.35M | 59.98%-229.24K | 69.38%-130.69K | -30.42%-621.49K | -51.08%-373.69K | 14.46%-1.75M | -11.32%-572.81K |
| Net non-operating interest income (expenses) | -4.48K | 0 | ||||||||
| Non-operating interest expense | ---- | ---- | ---- | --4.48K | ---- | ---- | ---- | ---- | --0 | ---- |
| Other net income (expenses) | -2,368.77%-48.61K | -1.97K | ||||||||
| Special income (charges) | ---- | ---- | --0 | -2,368.77%-48.61K | ---- | ---- | ---- | ---- | ---1.97K | ---- |
| -Less:Impairment of capital assets | ---- | ---- | --0 | --48.61K | ---- | ---- | ---- | ---- | --0 | ---- |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---4.24K | ---- |
| -Gain on sale of property,plant,equipment | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---6.21K | ---- |
| Income before tax | -174.80%-359.13K | 9.59%-561.9K | 11.97%-328.95K | 20.21%-1.4M | 50.88%-282.33K | 69.38%-130.69K | -30.42%-621.49K | -51.08%-373.69K | 14.51%-1.75M | -11.00%-574.78K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -174.80%-359.13K | 9.59%-561.9K | 11.97%-328.95K | 20.21%-1.4M | 50.88%-282.33K | 69.38%-130.69K | -30.42%-621.49K | -51.08%-373.69K | 14.51%-1.75M | -11.00%-574.78K |
| Net income continuous operations | -174.80%-359.13K | 9.59%-561.9K | 11.97%-328.95K | 20.21%-1.4M | 50.88%-282.33K | 69.38%-130.69K | -30.42%-621.49K | -51.08%-373.69K | 14.51%-1.75M | -11.00%-574.78K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -174.80%-359.13K | 9.59%-561.9K | 11.97%-328.95K | 20.21%-1.4M | 50.88%-282.33K | 69.38%-130.69K | -30.42%-621.49K | -51.08%-373.69K | 14.51%-1.75M | -11.00%-574.78K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -174.80%-359.13K | 9.59%-561.9K | 11.97%-328.95K | 20.21%-1.4M | 50.88%-282.33K | 69.38%-130.69K | -30.42%-621.49K | -51.08%-373.69K | 14.51%-1.75M | -11.00%-574.78K |
| Diluted earnings per share | -161.42%-0.0026 | 13.60%-0.004 | 17.92%-0.0025 | 50.00%-0.01 | 0 | 73.56%-0.001 | -0.26%-0.0047 | -24.60%-0.003 | 0.00%-0.02 | -0.01 |
| Basic earnings per share | -161.42%-0.0026 | 13.60%-0.004 | 17.92%-0.0025 | 50.00%-0.01 | 0 | 73.56%-0.001 | -0.26%-0.0047 | -24.60%-0.003 | 0.00%-0.02 | -0.01 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data